Analytikk SRL
The score of Analytikk shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -99 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Analytikk's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 130,801 € | ||||
| Equity | 3,000 € | ||||
| Cash | 13,064 € | ||||
| EBITDA | 195,194 € | ||||
| Total assets | 524,362 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 06 Feb 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
Analytikk's financial analysis
- Solvency0.6%sector median: 75.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Analytikk
Analytikk's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0755.963.461
- VAT number
- BE0755963461
- Peppol
- Registered · 0208:0755963461 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Oct 2020
- Registered office
- 9150 Beveren-Kruibeke-Zwijndrecht
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Analytikk (SRL) has been based in Beveren-Kruibeke-Zwijndrecht since 2020, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 130,801 € and equity of 3,000 €; its revenue is not published. Its solvency stands at 0.6%, below the median of its sector (75.0%).
Companies similar to Analytikk
Companies in the same business, of comparable size and area, outside its group.
- Arcom Diagnostic imaging services and medical laboratory activities Antwerp · balance sheet 141,138 €
- Cell-Cell BIO Research and experimental development on natural sciences and engineering Ghent · balance sheet 990,571 €
- Matsen Life Sciences Diagnostic imaging services and medical laboratory activities Londerzeel · balance sheet 73,064 €
- RPO NucleoGenesis Manufacture of basic pharmaceutical products Ghent · balance sheet 107,514 €
- Estrella Clinical Research Manufacture of basic pharmaceutical products Herentals · balance sheet 41,482 €
- Primrose Laboratories Manufacture of other chemical products n.e.c. Torhout · balance sheet €1.90m
- Cerdak Manufacture of pharmaceutical preparations Lanaken · balance sheet 103,436 €
- Evipa Diagnostic imaging services and medical laboratory activities Beveren-Kruibeke-Zwijndrecht · balance sheet €1.96m
Frequently asked questions about Analytikk
What is the revenue of Analytikk?
Analytikk files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Analytikk?
In Belgium, the VAT number is the company number prefixed with BE: BE0755963461 for Analytikk, if the company is VAT-registered. Its company number (CBE) is 0755.963.461.
Where is the registered office of Analytikk?
According to the CBE register, the registered office of Analytikk is in 9150 Beveren-Kruibeke-Zwijndrecht.
What is the equity of Analytikk?
At the close of the 2025 financial year, the equity of Analytikk amounts to 3,000 €, a solvency of 0.6% of total assets.
Who manages Analytikk?
The register lists 1 active mandates at Analytikk. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Analytikk
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →